Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: Analysis of 1145 lymph nodes

Lung Cancer

Volumn 60, Issue 1, 2008, Pages 62-68

  Al Sarraf, Nael ^a   Gately, Kathy ^a   Lucey, Julie ^b   Wilson, Lorraine ^b   McGovern, Eillish ^a   Young, Vincent ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b Blackrock Clinic Ireland   (Ireland)

Author keywords

Cervical mediastinoscopy; Lymph node staging; Positron emission tomography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE ENLARGEMENT; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41149088917     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.036     Document Type: Article

References (18)

1. Reed C.E., Harpole D.H., Posther K.E., Woolson S.L., Downey R.J., Meyers B.F., et al. Results of the American college of surgeons oncology group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126 6 (2003) 1943-1951
2. Cerfolio R.J., Ojha B., Bryant A.S., Raghuveer V., Mountz J.M., and Bartolucci A.A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
3. Van Tinteren H., Hoekstra O.S., Smit E.F., van den Bergh J.H., Schreurs A.J., Stallaert R.A., et al. Effectiveness of PET in the pre-operative assessment of patients with suspected non-small cell lung cancer: the PLUS multicenter randomised trial. Lancet 359 (2002) 1388-1392
4. De Leyn P., Lardinois D., Van Schil P., Rami-Porta R., Passlick B., Zielinski M., et al. European trends in preoperative and intraoperative nodal staging: ESTS guidelines. J Thorac Oncol 2 (2007) 357-361
5. World Health Organization. Histological typing of lung and pleural tumours. 3rd ed. (1999), Springer-Verlag, NewYork
6. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
7. Tisi G.M., Friedman P.H., and Peters R.M. American thoracic society: clinical staging of primary lung cancer. Am Rev Respir Dis 127 (1983) 659-664
8. Al-Sarraf N., Aziz R., Doddakula K., Gately K., Wilson L., McGovern E., et al. Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography. Interact Cardiovasc Thorac Surg 6 (2007) 350-353
9. Funatasu T., Matsbara Y., Ikeda S., Hatakenaka R., Hanawa T., and Ishida H. Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg 108 (1994) 321-328
10. Gdeedo A., Van Schil P., Corthouts B., Van Mieghem F., Van Meerbeeck J., and Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. EUR Respir J 10 (1997) 1547-1551
11. Leschber G., Holinka G., Feritag L., and Linder A. Mediastinoscopy in the staging of bronchial carcinoma-A critical assessment. Pneumologie 54 (2000) 489-493
12. Meyers B.F., Haddad F., Siegel B.A., Zoole J.B., Battafarano R.J., Veeramachaneni N., et al. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg 131 4 (2006) 822-829
13. Cerfolio R.J., Bryant A.S., and Eloubeidi M.A. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 130 (2006) 1791-1795
14. Konishi J., Yamazaki K., Tsukamoto E., Tamaki N., Onodera Y., Otake T., et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70 (2003) 500-506
15. Fischer B.M., and Mortensen J. The future in diagnosis and staging of lung cancer: positron emission tomography. Respiration 73 (2006) 267-276
16. Takamochi K., Yoshida J., Murakami K., Niho S., Ishii G., Nishimura M., et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 47 (2005) 235-242
17. Gupta N.C., Graeber G.M., and Bishop H.A. Comparative efficacy of positron emission tomography with Fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 117 (2000) 773-778
18. Shiraki N., Hara M., Ogino H., Shibamoto Y., Iida A., Tamaki T., et al. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET: radiological-pathological correlation. Ann Nucl Med 18 1 (2004) 23-28